Edesa Biotech (EDSA) Inventory (2014 - 2019)
Edesa Biotech's (EDSA) quarterly Inventory came in at $77913.0 in Q2 2019, down 67.19% year-over-year from $237494.0 in Q2 2018, and down 68.06% quarter-over-quarter from $243972.0 in Q1 2019.
Analysis
Edesa Biotech (EDSA) Inventory (2014 - 2019) Analysis & Trends
Edesa Biotech has disclosed Inventory across 6 years of filings, most recently posting $77913.0 for Q2 2019.
- In Q2 2019, Inventory fell 67.19% year-over-year to $77913.0; the TTM figure through Jun 2019 stood at $77913.0 (down 67.19% YoY), while the FY2018 annual figure was $224267.0, up 229.25% from the prior year.
- Inventory came in at $77913.0 for Q2 2019 at Edesa Biotech, down from $243972.0 in the prior quarter.
- In the past five years, Inventory ranged from a high of $568698.0 in Q2 2016 to a low of $68114.0 in Q3 2017.
- Average Inventory over 5 years is $278418.5, with a median of $237494.0 recorded in 2018.
- Year-over-year, Inventory jumped 302.12% in 2016 and sank 75.22% in 2017.
- Over 5 years, Inventory stood at $527958.0 in 2015, then slumped by 37.57% to $329583.0 in 2016, then sank by 64.03% to $118540.0 in 2017, then surged by 89.19% to $224267.0 in 2018, then plunged by 65.26% to $77913.0 in 2019.
- Per Business Quant data, the three most recent Inventory figures were $77913.0 in Q2 2019, $243972.0 in Q1 2019, and $224267.0 in Q3 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.59 Bn | 192.60 Bn | 7.24 Bn | 6.22 Bn |
| 2 | Gilead Sciences | 180.21 Bn | 177.03 Bn | 6.22 Bn | 1.95 Bn |
| 3 | Vertex Pharmaceuticals | 131.41 Bn | 123.56 Bn | 2.84 Bn | 1.77 Bn |
| 4 | Regeneron Pharmaceuticals | 81.94 Bn | 73.94 Bn | 3.93 Bn | 3.08 Bn |
| 5 | Argenx Se | 60.60 Bn | 55.41 Bn | 1.37 Bn | 371.00 Mn |
| 6 | Moderna | 53.61 Bn | 48.47 Bn | 52.00 Mn | 280.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.49 Bn | 30.18 Bn | 992.69 Mn | 97.11 Mn |
| 8 | Biogen | 31.83 Bn | 30.54 Bn | 1.96 Bn | 2.38 Bn |
| 9 | Roivant Sciences | 29.14 Bn | 29.14 Bn | 1.16 Mn | - |
| 10 | Edesa Biotech | 43.24 Mn | 43.24 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2019 | 77,913.00 |
| Mar 31, 2019 | 243,972.00 |
| Sep 30, 2018 | 224,267.00 |
| Jun 30, 2018 | 237,494.00 |
| Mar 31, 2018 | 205,364.00 |
| Dec 31, 2017 | 118,540.00 |
| Sep 30, 2017 | 68,114.00 |
| Jun 30, 2017 | 140,947.00 |
| Mar 31, 2017 | 310,574.00 |
| Dec 31, 2016 | 329,583.00 |
| Sep 30, 2016 | 249,430.00 |
| Jun 30, 2016 | 568,698.00 |
| Mar 31, 2016 | 543,463.00 |
| Dec 31, 2015 | 527,958.00 |
| Sep 30, 2015 | 557,280.00 |
| Jun 30, 2015 | 194,367.00 |
| Mar 31, 2015 | 135,151.00 |
| Dec 31, 2014 | 134,308.00 |